$Novo-Nordisk A/S(NVO)$ view o

$Novo-Nordisk A/S(NVO)$ view order details.@Trade Feed Decoder

NVO

08-04 08:03

USNovo-Nordisk A/S

Side	Price \| Filled	Realized P&L
Buy Open	48.90 30	-- Closed

Novo-Nordisk A/S

Trade Feed: Who is your favorite trader?

Come to the Trade Feed Topic to find more trading opportunities! Also, please feel free to recommend and introduce fellow Tigers to the "hidden gem traders" that you've discovered!

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

Trade Feed Decoder
08-04
Trade Feed Decoder
**Analysis of Novo-Nordisk (NVO) Trade** The trade reflects a minor realized loss (-1.16%), likely influenced by short-term volatility despite Novo-Nordisk's strong long-term fundamentals in diabetes and obesity care. The entry at $48.9 aligns with the stock’s historical consolidation patterns, suggesting a potential mean-reversion or breakout strategy. Position sizing appears conservative given the limited loss magnitude, indicating disciplined risk management. However, the timing might coincide with sector-specific headwinds (e.g., regulatory scrutiny or competitor updates) impacting sentiment. The trade highlights the challenge of timing entries in large-cap healthcare stocks, where macro factors often outweigh company-specific catalysts. Emphasis on cutting losses early aligns with a risk-averse approach common in volatile biopharma markets.
KSR
08-04
KSR
👍

Leave a comment

149

{"i18n":{"language":"en_US"},"detailType":1,"isChannel":false,"data":{"magic":2,"id":463763576246488,"tweetId":"463763576246488","gmtCreate":1754265983768,"gmtModify":1754484460339,"author":{"id":4107236002894590,"idStr":"4107236002894590","authorId":4107236002894590,"authorIdStr":"4107236002894590","name":"Polkadottie","avatar":"https://community-static.tradeup.com/news/b1e49bcd659490d5047204bf4aacfece","vip":1,"userType":1,"introduction":"","boolIsFan":false,"boolIsHead":false,"crmLevel":12,"crmLevelSwitch":0,"individualDisplayBadges":[],"fanSize":230,"starInvestorFlag":true,"fullDisclosureFlag":true,"starInvestorFollowerNum":225,"starInvestorOrderShareNum":749,"userFollowInvestorFlag":false,"orderNotificationFlag":false,"ror":151.56,"showRor":true,"winRationPercentage":54.545455,"tradeVolumeEst":0},"themes":[{"themeId":"4e1ab37448a24dd39b7882426fc6fd27","categoryId":"ab3d937a5fd848c08008411a9be702b5","name":"Trade Feed: Who is your favorite trader?","type":0,"rnLink":"https://laohu8.com/RN?name=RNTheme&page=/theme/detail&rndata={\"themeId\":4e1ab37448a24dd39b7882426fc6fd27}&rnconfig={\"headerBarHidden\": true}","description":"Come to the Trade Feed Topic to find more trading opportunities! Also, please feel free to recommend and introduce fellow Tigers to the \"hidden gem traders\" that you've discovered!","image":"https://community-static.tradeup.com/news/e496e574dd744490c7b4f7959f83f5a4"}],"images":[],"coverImages":[],"html":"<html><head></head><body><a href=\"https://ttm.financial/S/NVO\">$Novo-Nordisk A/S(NVO)$&nbsp;</a>view order details.<a href=\"https://ttm.financial/U/10000000000011061\">@Trade Feed Decoder</a></body></html>","htmlText":"<html><head></head><body><a href=\"https://ttm.financial/S/NVO\">$Novo-Nordisk A/S(NVO)$&nbsp;</a>view order details.<a href=\"https://ttm.financial/U/10000000000011061\">@Trade Feed Decoder</a></body></html>","text":"$Novo-Nordisk A/S(NVO)$ view order details.@Trade Feed Decoder","highlighted":1,"essential":1,"paper":1,"likeSize":149,"commentSize":2,"repostSize":96,"favoriteSize":0,"link":"https://ttm.financial/post/463763576246488","repostId":0,"isVote":1,"tweetType":1,"viewCount":5020,"commentLimit":10,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"symbols":["NVO"],"verified":2,"subType":0,"readableState":1,"langContent":"EN","currentLanguage":"EN","warmUpFlag":false,"orderFlag":true,"orderData":{"uuid":"4107236002894590","orderId":"40025014149714944","kind":"TRADE","symbol":"NVO","secType":"STK","symbolHtmlTag":"<a href=\"https://ttm.financial/S/NVO\">$Novo-Nordisk A/S(NVO)$&nbsp;</a>","symbolHtmlTagHref":"https://ttm.financial/S/NVO","symbolName":"Novo-Nordisk A/S","market":"US","action":"BUY","currency":"USD","symbolLogo":"https://static.tigerbbs.com/4454e2be594d73a2a7bfa9c42bfb69f7","showFilledQuantity":true,"nameCN":"Novo-Nordisk A/S","orderType":"LMT","filledQuantityFinal":30,"avgFillPrice":48.9,"createTime":1754265824,"filledQuantity":"30","filledQuantityScale":"0","openFlag":true,"side":"DEBIT","contractMajorDescription":"Novo-Nordisk A/S","contractExtraDescription":"NVO","legs":[],"completedFlag":true,"orderPnl":{"openRealizedPnlPercent":-0.067},"quickOrderFlag":false},"shareable":true,"causeOfNotShareable":"","featuresForAnalytics":["订单分享帖","未分享订单分享帖"],"commentAndTweetFlag":false,"andRepostAutoSelectedFlag":false,"upFlag":false,"length":34,"optionInvolvedFlag":false,"xxTargetLangEnum":"ORIG"},"commentList":[{"id":463836367503752,"commentId":"463836367503752","gmtCreate":1754272835462,"gmtModify":1754274344759,"authorId":10000000000011060,"author":{"id":10000000000011060,"idStr":"10000000000011061","authorId":10000000000011060,"name":"Trade Feed Decoder","avatar":"https://community-static.tradeup.com/news/4dc8fec78bad5acffbf563bdbc6bc8ed","vip":4,"crmLevel":1,"crmLevelSwitch":0,"individualDisplayBadges":[]},"repliedAuthorId":0,"objectId":463763576246488,"objectIdStr":"463763576246488","type":1,"supId":0,"supIdStr":"0","prevId":0,"prevIdStr":"0","content":"**Analysis of Novo-Nordisk (NVO) Trade**  \nThe trade reflects a minor realized loss (-1.16%), likely influenced by short-term volatility despite Novo-Nordisk's strong long-term fundamentals in diabetes and obesity care. The entry at $48.9 aligns with the stock’s historical consolidation patterns, suggesting a potential mean-reversion or breakout strategy. Position sizing appears conservative given the limited loss magnitude, indicating disciplined risk management. However, the timing might coincide with sector-specific headwinds (e.g., regulatory scrutiny or competitor updates) impacting sentiment. The trade highlights the challenge of timing entries in large-cap healthcare stocks, where macro factors often outweigh company-specific catalysts. Emphasis on cutting losses early aligns with a risk-averse approach common in volatile biopharma markets.","text":"**Analysis of Novo-Nordisk (NVO) Trade**  \nThe trade reflects a minor realized loss (-1.16%), likely influenced by short-term volatility despite Novo-Nordisk's strong long-term fundamentals in diabetes and obesity care. The entry at $48.9 aligns with the stock’s historical consolidation patterns, suggesting a potential mean-reversion or breakout strategy. Position sizing appears conservative given the limited loss magnitude, indicating disciplined risk management. However, the timing might coincide with sector-specific headwinds (e.g., regulatory scrutiny or competitor updates) impacting sentiment. The trade highlights the challenge of timing entries in large-cap healthcare stocks, where macro factors often outweigh company-specific catalysts. Emphasis on cutting losses early aligns with a risk-averse approach common in volatile biopharma markets.","html":"**Analysis of Novo-Nordisk (NVO) Trade**  \nThe trade reflects a minor realized loss (-1.16%), likely influenced by short-term volatility despite Novo-Nordisk's strong long-term fundamentals in diabetes and obesity care. The entry at $48.9 aligns with the stock’s historical consolidation patterns, suggesting a potential mean-reversion or breakout strategy. Position sizing appears conservative given the limited loss magnitude, indicating disciplined risk management. However, the timing might coincide with sector-specific headwinds (e.g., regulatory scrutiny or competitor updates) impacting sentiment. The trade highlights the challenge of timing entries in large-cap healthcare stocks, where macro factors often outweigh company-specific catalysts. Emphasis on cutting losses early aligns with a risk-averse approach common in volatile biopharma markets.","likeSize":0,"commentSize":0,"subComments":[],"verified":10,"allocateAmount":0,"commentType":"hot","coins":0,"score":0,"disclaimerFlag":true,"disclaimerType":1,"specialCommentTag":"AI_ANALYSE"},{"id":463847230661032,"commentId":"463847230661032","gmtCreate":1754273578768,"gmtModify":1754273582566,"authorId":4121076730674632,"author":{"id":4121076730674632,"idStr":"4121076730674632","authorId":4121076730674632,"name":"KSR","avatar":"https://community-static.tradeup.com/news/7326507c34f41020b4293ec0bc34a77a","vip":1,"crmLevel":11,"crmLevelSwitch":1,"individualDisplayBadges":[]},"repliedAuthorId":0,"objectId":463763576246488,"objectIdStr":"463763576246488","type":1,"supId":0,"supIdStr":"0","prevId":0,"prevIdStr":"0","content":"👍","text":"👍","html":"👍","likeSize":0,"commentSize":0,"subComments":[],"verified":10,"allocateAmount":0,"commentType":"invalid","coins":0,"score":0,"disclaimerType":0}],"isCommentEnd":false,"isTiger":false,"isWeiXinMini":false,"url":"/m/post/463763576246488"}